Alumis (ALMS) Shares Outstanding (2023 - 2026)
Alumis (ALMS) posted quarterly Shares Outstanding (Entity) of $85.1 million for Q4 2025, up 197.75% year-over-year from $28.6 million in Q4 2024, and down 18.46% quarter-over-quarter from $104.4 million in Q3 2025.
Alumis (ALMS) Shares Outstanding (2023 - 2026) Analysis & Trends
Alumis (ALMS) has reported Shares Outstanding (Entity) for 3 consecutive years, with $85.1 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Shares Outstanding (Entity) rose 197.75% year-over-year to $85.1 million; the TTM figure through Dec 2025 stood at $85.1 million (up 197.75% YoY), while the FY2025 annual figure was $85.1 million, up 197.75% from the prior year.
- Shares Outstanding (Entity) declined to $85.1 million in Q4 2025 per ALMS's latest filing, from $104.4 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $104.4 million in Q3 2025 and bottomed at $2.6 million in Q2 2023.
- Historically, Shares Outstanding (Entity) has averaged $42.6 million across 3 years, with a median of $33.1 million in 2024.
- Annual changes were most pronounced in 2024 — Shares Outstanding (Entity) increased 3.56% — and 2025, when it jumped 2692.62%.
- Alumis' Shares Outstanding (Entity) stood at $23.8 million in 2023, then rose by 19.88% to $28.6 million in 2024, then jumped by 197.75% to $85.1 million in 2025.
- Business Quant data shows ALMS's Shares Outstanding (Entity) at $85.1 million in Q4 2025, $104.4 million in Q3 2025, and $76.6 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.19 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 210.89 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.45 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.05 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 445.06 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.61 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Alumis | 3.25 Bn | 2.75 Bn | - | 127.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 127.70 Mn |
| Dec 31, 2025 | 85.10 Mn |
| Sep 30, 2025 | 104.15 Mn |
| Jun 30, 2025 | 76.56 Mn |
| Mar 31, 2025 | 54.41 Mn |
| Dec 31, 2024 | 28.58 Mn |
| Sep 30, 2024 | 53.97 Mn |
| Jun 30, 2024 | 2.70 Mn |
| Mar 31, 2024 | 33.05 Mn |
| Dec 31, 2023 | 23.84 Mn |
| Sep 30, 2023 | 2.65 Mn |
| Jun 30, 2023 | 2.64 Mn |